What Does Reverse T3 Tell You?
Reverse T3 (rT3) is primarily a marker of non-thyroidal illness and metabolic stress rather than a useful indicator of thyroid dysfunction requiring treatment. The test has limited clinical utility in routine practice and should not be used to guide thyroid hormone replacement decisions.
Clinical Significance of rT3
rT3 is a biologically inactive metabolite produced when T4 is converted by type 1 and type 3 deiodinase enzymes (D1 and D3). According to the French Endocrine Society guidelines, serum rT3 concentration depends on confounding factors such as general, severe or consumptive disease 1. When these acute pathologies are absent, aging is often accompanied by reduced deiodinase type 1 activity, leading to rT3 elevation 1.
Key Clinical Contexts Where rT3 Rises:
- Non-thyroidal illness syndrome (formerly "euthyroid sick syndrome") - during severe acute illness, rT3 typically increases while T3 decreases 2
- Critical illness - elevated rT3 was independently associated with ICU mortality in clinical patients (OR: 2.436) 3
- Medications - particularly amiodarone, which inhibits rT3 metabolism 2
- Physiological stress, trauma, and chronic inflammation 4
Why rT3 Testing Has Limited Clinical Utility
The French Endocrine Society explicitly recommends against thyroid assessment during acute illness unless it would alter ongoing treatment (Grade 1+++) 1. This is because thyroid function tests, including rT3, are often non-specifically disturbed in general non-thyroid disease.
Evidence Against Routine rT3 Testing:
A 2018 analysis of national laboratory data revealed striking practice variation: only 0.1% of providers accounted for 29.5% of all rT3 orders, with 60% of high-volume orderers classified as functional medicine practitioners 5. The systematic review accompanying this study found little indexed literature evidence to support high volumes of rT3 testing 5.
Common Pitfalls to Avoid
The "rT3 Dominance" Myth
Some practitioners, particularly in functional medicine, claim that elevated rT3 blocks T3 from binding to thyroid hormone receptors and requires T3-only replacement therapy 6, 5. However:
- This concept lacks support in mainstream endocrinology guidelines - none of the major thyroid society guidelines (American Thyroid Association, French Endocrine Society, USPSTF) recommend rT3 testing for treatment decisions
- rT3 binds weakly to thyroid nuclear hormone receptors and is considered an inactive end-product 2
- The clinical relevance of extra-nuclear rT3 receptor binding remains unproven 2
When NOT to Order rT3:
- Do not order during acute hospitalization or intercurrent illness - values will be elevated but reflect stress response, not thyroid dysfunction 1
- Do not use to guide thyroid hormone replacement - no guideline-level evidence supports this practice
- Do not order in patients with normal TSH and no symptoms - adds no actionable information
Rare Legitimate Uses
rT3 measurement may provide diagnostic value in:
- Genetic conditions affecting iodothyronine deiodinases - provides a diagnostic fingerprint 2
- Thyroid transporter or transport protein disorders 2
- Research settings to understand thyroid hormone metabolism
Practical Approach
If you encounter an elevated rT3 result:
- Assess for acute illness or stress - this is the most common cause and requires no thyroid-specific intervention
- Review medications - particularly amiodarone
- Check standard thyroid function (TSH, free T4) - if normal, reassure the patient
- Do not initiate T3-only therapy based on rT3 elevation alone
- Repeat testing after resolution of acute illness if thyroid dysfunction is suspected (typically 4-12 months later) 1
The bottom line: rT3 elevation reflects metabolic adaptation to illness or stress, not a treatable thyroid disorder. Standard thyroid function testing (TSH, free T4, and when indicated, free T3) remains the appropriate approach for evaluating thyroid status 1.